{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:26:37Z","timestamp":1792801597376,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2005,3,1]]},"DOI":"10.1038\/sj.pcan.4500782","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T10:41:48Z","timestamp":1107254508000},"page":"75-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole"],"prefix":"10.1038","volume":"8","author":[{"given":"D","family":"Saltzstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,2,1]]},"reference":[{"key":"BF4500782_CR1","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1097\/01.ju.0000140159.94703.80","volume":"172","author":"MP Wirth","year":"2004","unstructured":"Wirth MP et al. Bicalutamide 150\u2009mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years. J Urol 2004; 172: 1865\u20131870.","journal-title":"J Urol"},{"key":"BF4500782_CR2","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0022-5347(05)67032-2","volume":"164","author":"P Iversen","year":"2000","unstructured":"Iversen P et al. Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup. J Urol 2000; 164: 1579\u20131582.","journal-title":"J Urol"},{"key":"BF4500782_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0090-4295(00)00823-2","volume":"56","author":"DG McLeod","year":"2000","unstructured":"McLeod DG, Iversen P . Gynecomastia in patients with prostate cancer: a review of treatment options. Urology 2000; 56: 713\u2013720.","journal-title":"Urology"},{"key":"BF4500782_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2265.1994.tb02585.x","volume":"41","author":"J Verhelst","year":"1994","unstructured":"Verhelst J et al. Endocrine profiles during administration of the new non-steroidal anti-androgen Casodex in prostate cancer. Clin Endocrinol (Oxf) 1994; 41: 525\u2013530.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF4500782_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ijrobp.2004.03.022","volume":"60","author":"CJ Tyrrell","year":"2004","unstructured":"Tyrrell CJ et al. Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10\u2009Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. Int J Radiat Oncol Phys Biol 2004; 60: 476\u2013483.","journal-title":"Int J Radiat Oncol Phys Biol"},{"key":"BF4500782_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0090-4295(02)02107-6","volume":"61","author":"A Widmark","year":"2003","unstructured":"Widmark A et al. Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7\/SFUO-3. Urology 2003; 61: 145\u2013151.","journal-title":"Urology"},{"key":"BF4500782_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1677\/erc.0.0060315","volume":"6","author":"GD Braunstein","year":"1999","unstructured":"Braunstein GD . Aromatase and gynecomastia. Endocr Relat Cancer 1999; 6: 315\u2013324.","journal-title":"Endocr Relat Cancer"},{"key":"BF4500782_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0026-0495(86)90237-4","volume":"35","author":"LN Parker","year":"1986","unstructured":"Parker LN, Gray DR, Lai MK, Levin ER . Treatment of gynecomastia with tamoxifen: a double-blind crossover study. Metabolism 1986; 35: 705\u2013708.","journal-title":"Metabolism"},{"key":"BF4500782_CR9","first-page":"483","volume":"9","author":"TT Alagaratnam","year":"1987","unstructured":"Alagaratnam TT . Idiopathic gynecomastia treated with tamoxifen: a preliminary report. Clin Ther 1987; 9: 483\u2013487.","journal-title":"Clin Ther"},{"key":"BF4500782_CR10","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1097\/00007611-199011000-00013","volume":"83","author":"MT McDermott","year":"1990","unstructured":"McDermott MT, Hofeldt FD, Kidd GS . Tamoxifen therapy for painful idiopathic gynecomastia. South Med J 1990; 83: 1283\u20131285.","journal-title":"South Med J"},{"key":"BF4500782_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0090-4295(97)00457-3","volume":"50","author":"VR Staiman","year":"1997","unstructured":"Staiman VR, Lowe FC . Tamoxifen for flutamide\/finasteride-induced gynecomastia. Urology 1997; 50: 929\u2013933.","journal-title":"Urology"},{"key":"BF4500782_CR12","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0022-5347(01)63595-X","volume":"59","author":"S Serels","year":"1998","unstructured":"Serels S, Melman A . Tamoxifen as treatment for gynecomastia and mastodynia resulting from hormonal deprivation. J Urol 1998; 59: 1309.","journal-title":"J Urol"},{"key":"BF4500782_CR13","first-page":"1697","volume":"11","author":"PE Goss","year":"1997","unstructured":"Goss PE, Tye LM . Anastrozole: a new selective nonsteroidal aromatase inhibitor. Oncology (Huntingt) 1997; 11: 1697\u20131703.","journal-title":"Oncology (Huntingt)"},{"key":"BF4500782_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2605.1992.tb01110.x","volume":"15","author":"W Krause","year":"1992","unstructured":"Krause W, Holland-Moritz H, Schramm P . Treatment of idiopathic oligozoospermia with tamoxifen\u2014a randomized controlled study. Int J Androl 1992; 15: 14\u201318.","journal-title":"Int J Androl"},{"key":"BF4500782_CR15","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/S0022-5347(01)66709-0","volume":"154","author":"MS Soloway","year":"1995","unstructured":"Soloway MS et al. Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II noncomparative multicenter trial evaluating safety, efficacy and long-term endocrine effects of monotherapy. J Urol 1995; 154: 2110\u20132114.","journal-title":"J Urol"},{"key":"BF4500782_CR16","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1046\/j.1464-410X.2002.02650.x","volume":"89","author":"HS Ahn","year":"2002","unstructured":"Ahn HS, Park CM, Lee SW . The clinical relevance of sex hormone levels and sexual activity in the ageing male. BJU Int 2002; 89: 526\u2013530.","journal-title":"BJU Int"},{"key":"BF4500782_CR17","first-page":"39","volume":"33","author":"CJ Tyrrell","year":"1998","unstructured":"Tyrrell CJ et al. Casodex\u2122 10-200\u2009mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three Phase II dose-ranging studies. Eur Urol 1998; 33: 39\u201353.","journal-title":"An overview of the efficacy, tolerability and pharmacokinetics from three Phase II dose-ranging studies. Eur Urol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4500782.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4500782","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4500782.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:52:03Z","timestamp":1648680723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4500782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,3,1]]}},"alternative-id":["BF4500782"],"URL":"https:\/\/doi.org\/10.1038\/sj.pcan.4500782","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,1]]},"assertion":[{"value":"23 July 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2004","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2004","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}